Prevention and control of highly pathogenic avian influenza with particular reference to H5N1

Virus Research

Volumn 178, Issue 1, 2013, Pages 114-120

  Capua, Ilaria ^a   Cattoli, Giovanni ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

Avian influenza H5N1; Control; Prevention; Vaccination

Indexed keywords

AVIAN INFLUENZA VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; RECOMBINANT VACCINE;

ARTICLE; AVIAN INFLUENZA; CLEANING; COCCIDIOSIS; CONTROL STRATEGY; DISEASE ERADICATION; DISINFECTION; ECONOMIC ASPECT; EGYPT; GOOSE; GOVERNMENT; HONG KONG; HYGIENE; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; NONHUMAN; POULTRY; PRIORITY JOURNAL; VETERINARY CLINIC; VIET NAM; VIRUS MUTATION;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS;

AVIAN INFLUENZA H5N1; CONTROL; PREVENTION; VACCINATION;

ANIMALS; BIRDS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84887622932     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.04.002     Document Type: Article

References (53)

1. Abdelwhab E.M., Selim A.A., Arafa A., Galal S., Kilany W.H., Hassan M.K., Aly M.M., Hafez M.H. Circulation of Avian Influenza H5N1 in live bird markets in Egypt. Avian Diseases 2010, 54(2):911-914.
2. Amonsin A., Choatrakol C., Lapkuntod J., Tantilertcharoen R., Thanawongnuwech R., Suradhat S., Suwannakarn K., Theamboonlers A., Poovorawan Y. Influenza virus (H5N1) in live bird markets and food markets, Thailand. Emerging Infectious Diseases 2008, 14:1739-1742.
3. Bankowski R.A. Report of the Committee on Transmissible Diseases of Poultry and Other Avian Species. Proceedings of the 88th Annual Meeting of the U.S. Animal Health Association 1985, 474-483.
4. Beard C.W., Schnitzlein W.M., Tripathy D.N. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Diseases 1991, 35(2):356-359.
5. Capua I., Alexander D.J. Avian influenza: recent developments. Avian Pathology 2004, 33:393-404.
6. Capua I., Marangon S. The avian influenza epidemic in Italy, 1999-2000: a review. Avian Pathology 2000, 29:289-294.
7. Capua I., Marangon S. The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy. Vaccine 2007, 25:4987-4995.
8. Capua I., Terregino C., Cattoli G., Toffan A. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathology 2004, 33:158-163.
9. Cattoli G., Fusaro A., Monne I., Coven F., Joannis T., El-Hamid H.S., Hussein A.A., Cornelius C., Amarin N.M., Mancin M., Holmes E.C., Capua I. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 2011, 29(50):9368-9375.
10. Chen H. Avian influenza vaccination: the experience in China. Revue scientifique et technique (International Office of Epizootics) 2009, 28:267-274.
11. DEFRA, 2005. Epidemiology report on avian influenza in a quarantine premises in Essex. https://docs.google.com/viewer?url=http://www.eponet.org/pdf/ai-epidemrep111105.pdf.
12. Desvaux S., Grosbois V., Pham T.T.H., Dao D.T., Nguyen T.D., Fenwick S., Roger F., Ellis T., Peyre M. Evaluation of the vaccination efficacy against H5N1 in domestic poultry in the Red River Delta in Vietnam. Epidemiology and Infection 2012, 1-13.
13. Domenech J., Dauphin G., Rushton J., McGrane J., Lubroth J., Tripodi A., Gilbert J., Sims L.D. Experiences with vaccination in countries endemically infected with highly pathogenic avian influenza: the Food and Agriculture Organization perspective. Revue scientifique et technique (International Office of Epizootics) 2009, 28:293-305.
14. EFSA Scientific panel on animal health and animal welfare. Animal health and welfare aspects of Avian Influenza. Annex to The EFSA Journal 2005, 266:1-21.
15. FAO, 2009. ftp://ftp.fao.org/docrep/fao/011/ai326e/ai326e00.pdf (accessed 13.09.12).
16. FAO, 2011a. http://www.fao.org/docrep/014/i2150e/i2150e.pdf (accessed 13.09.12).
17. FAO, 2011b. http://www.fao.org/docrep/014/al873e/al873e00.pdf (accessed 13.09.12).
18. Fasina F.O., Meseko A.C., Joannis T.M., Shittu A.I., Ularamu H.G., Egbuji N.A., Sulaiman L.K., Onyekonwu N.O. Control versus no control: options for avian influenza H5N1 in Nigeria. Zoonoses Public Health 2007, 54(5):173-176.
19. Fasina F.O., Ali A.M., Yilma J.M., Thieme O., Ankers P. The cost - benefit of biosecurity measures on infectious diseases in the Egyptian household poultry. Preventive Veterinary Medicine 2012, 103:178-191.
20. Garcia-Garcia J., Rodriguez V.H., Hernandez M.A. Experimental studies in field trials with recombinant fowlpox vaccine in broilers in Mexico. Proceedings of the Fourth International Symposium on Avian Influenza, Athens, Georgia, USA 1998, 245-252. U.S. Animal Health Association. D.E. Swayne, R.D. Slemons (Eds.).
21. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of Virology 2007, 81:150-158.
22. Halvorson D.A. Strengths and weaknesses of vaccines as a control tool. Proceedings of the Fourth International Symposium on Avian Influenza, Athens, Georgia, USA 1998, 223-227. U.S. Animal Health Association. D.E. Swayne, R.D. Slemons (Eds.).
23. Kapczynski D.R., Swayne D.E. Influenza vaccines for avian species. Current Topics in Microbiology and Immunology 2009, 333:133-152.
24. Kim J.-K., Kayali G., Walker D., Forrest H.L., Ellebedy A.H., Griffin Y.S., Rubrum A., Bahgat M.M., Kutkat M.A., Ali M.A.A., Aldridge J.R., Negovetich N.J., Krauss S., Webby R.J., Webster R.G. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11044-11049.
25. Kung N.Y., Guan Y., Perkins N.R., Bissett L., Ellis T., Sims L., Morris R.S., Shortridge K.F., Peiris J.S.M. The impact of a monthly rest day on avian influenza virus isolation rates in retail live poultry markets in Hong Kong. Avian Diseases 2003, 47:1037-1041.
26. Lau E.H.Y., Leung Y.H.C., Zhang L.J., Cowling B.J., Mak S.P., Guan Y., Leung G.M., Peiris J.S.M. Effect of interventions on Influenza A (H9N2) Isolation in Hong Kong' s Live Poultry Markets, 1999-2005. Emerging Infectious Diseases 2007, 13(9):1999-2005.
27. Lüschow D., Werner O., Mettenleiter T.C., Fuchs W. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 2001, 19:4249-4259.
28. Mona, A.M., Samaha, H.A., Galal, S.A., Ahmed, Z., Schwabenbauer, K., 2009. FAO study on the presence of highly pathogenic avian influenza (HPAI) virus and Newcastle disease virus in live bird markets in Tanta District, Gharbia Governorate, Egypt. AHBL 2009 - Promoting strategies for prevention and control of HPAI.
29. Nakaya T., Cros J., Park M., Nakaya Y., Zheng H., Palese P., Sagrera A.N.A., Villar E., Garci A. Recombinant Newcastle disease virus as a vaccine vector. Journal of Virology 2001, 75(23):11868-11873.
30. Negovetich N.J., Feeroz M.M., Jones-Engel L., Walker D., Alam S.M.R., Hasan K., Seiler P., Ferguson A., Friedman K., Barman S., Franks J., Turner J., Krauss S., Webby R.J., Webster R.G. Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza. PloS ONE 2011, 6:e19311.
31. Otte J., Hinrichs J., Rushton J., Roland-Holst D., Zilberman D. Impacts of avian influenza virus on animal production in developing countries. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources 2008, 3:1-18.
32. Peyre M., Fusheng G., Desvaux S., Roger F. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiology and Infection 2009, 137:1-21.
33. Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., Ettel T., Dauphin G., Lubroth J., Roger F., Domenech J. Avian influenza vaccination in Egypt: limitations of the current strategy. Journal of Molecular and Genetic Medicine 2009, 3:198-204.
34. Philippa J., Baas C., Beyer W., Bestebroer T., Fouchier R., Smith D., Schaftenaar W., Osterhaus A. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 2007, 25:3800-3808.
35. Qiao C.-L., Yu K.-Z., Jiang Y.-P., Jia Y.-Q., Tian G.-B., Liu M., Deng G.-H., Wang X.-R., Meng Q.-W., Tang X.-Y. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathology 2003, 32:25-32.
36. Samaan G., Gultom A., Indriani R., Lokuge K., Kelly P.M. Critical control points for avian influenza A H5N1 in live bird markets in low resource settings. Preventive Veterinary Medicine 2011, 100(1):71-78.
37. Senne D.A., Pearson J.E., Panigrahy B. Live bird markets: a missing link in the epidemiology of avian influenza. Proceedings of the 3rd International Symposium on Avian Influenza 1992 1993, 50-80.
38. Senne D.A., Pedersen J.C., Panigrahy B. Live-bird markets in the Northeastern United States: a source of avian influenza in commercial poultry. Avian influenza, Prevention and Control 2005, vol. 8:19-24. Wageningen UR Frontis.
39. Shi H., Liu X.F., Zhang X., Chen S., Sun L., Lu J. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine 2007, 25:7379-7384.
40. Song J.M., Lee Y.J., Jeong O.M., Kang H.M., Kim H.R., Kwon J.H., Kim J.H., Seong B.L., Kim Y.J. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea. Veterinary Microbiology 2008, 130:268-276.
41. Spackman E., Swayne D.E. Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technologies. Virus Research 2013, 10.1016/j.virusres.2013.03.004.
42. Subbarao K., Chen H., Swayne D., Mingay L., Fodor E., Brownlee G., Xu X., Lu X., Katz J., Cox N., Matsuoka Y. Evaluation of a genetically modified reassortant H5N1 Influenza A Virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003, 305:192-200.
43. Swayne D.E., Mickle T.R. Protection of chickens against highly pathogenic Mexican-origin H5N2 avian influenza virus by a recombinant fowlpox vaccine. Proceedings the 100th Annual Meeting of the US Animal Health Association 1997, 557-563.
44. Swayne D.E., Pavade G., Hamilton K., Vallat B., Miyagishima K. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry. Revue Scientifique et Technique 2011, 30:839-870.
45. Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 2005, 341:153-162.
46. Tumpey T.M., Alvarez R., Swayne D.E., Suarez D.L. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of Influenza A Virus. Journal of Clinical Microbiology 2005, 43:676-683.
47. USDA, 2011. http://www.aphis.usda.gov/import_export/animals/nonus_pet_bird.shtml.
48. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., Mundt E., Schirrmeier H., Mebatsion T., Mettenleiter T.C., Römer-Oberdörfer A. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:8197-8202.
49. Webster R.G., Peiris M., Chen H., Guan Y. H5N1 outbreaks and enzootic influenza. Emerging Infectious Diseases 2006, 12:3-8.
50. Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.-J., Seiler P., Krauss S., Songserm T. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 2006, 351:303-311.
51. van der Goot J.A., Koch G., de Jong M.C., van Boven M. Quantification of the effect of transmission of avian influenza (H7N7) in chickens. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:18141-18146.
52. van der Goot J.A., van Boven M., Koch G., de Jong M.C. Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals. Vaccine 2007, 25:8318-8325.
53. Zanella A., Poli G., Bignami M. Avian influenza: Approaches in the control of disease with inactivated vaccines in oil emulsion. Proceedings of the First International Symposium on Avian influenza 1981, 180-183.